The Pharmaletter

One To Watch

hyloris_company

Hyloris Pharmaceuticals

A Belgian company focused on adding value to the healthcare system by reformulating well-known pharmaceuticals.

The company began trading on Euronext Brussels, using the ticker symbol HYL, in June 2020, with a total offering size amounting to 61.8 million euros ($69 million), or 71 million euros, assuming the exercise in full of the over-allotment option.

Hyloris intends to use the proceeds of the IPO to fund the development of its existing portfolio of product candidates, the establishment of a commercial team in the USA for its intravenous cardiovascular portfolio, as well as the expansion of its product pipeline.

Want to Update your Company's Profile?


Latest Hyloris Pharmaceuticals News

More Hyloris Pharmaceuticals news >